Literature DB >> 5676802

Correlation of performance test scores with "tissue concentration" of lysergic acid diethylamide in human subjects.

J G Wagner, G K Aghajanian, O H Bing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5676802     DOI： 10.1002/cpt196895635

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  7 in total

1.  Determinants of response to frusemide in normal subjects.

Authors:  R A Branch; C J Roberts; M Homeida; D Levine
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

Review 2.  Kinetic-effect models and their applications.

Authors:  J Grevel
Journal:  Pharm Res       Date:  1987-04       Impact factor: 4.200

3.  Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects.

Authors:  Friederike Holze; Urs Duthaler; Patrick Vizeli; Felix Müller; Stefan Borgwardt; Matthias E Liechti
Journal:  Br J Clin Pharmacol       Date:  2019-04-29       Impact factor: 4.335

4.  Influence of intravenous infusion duration on the tissue drug concentration profile.

Authors:  D A Uccellini; K Raymond; D J Morgan
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

5.  Relationships between several pharmacokinetic parameters and psychometric indices of subjective effects of delta 9-tetrahydrocannabinol in man.

Authors:  L L Miller; D M Cocchetto; M Perez-Reyes
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 6.  Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models.

Authors:  N H Holford; L B Sheiner
Journal:  Clin Pharmacokinet       Date:  1981 Nov-Dec       Impact factor: 6.447

7.  Pharmacokinetics and Pharmacodynamics of Lysergic Acid Diethylamide in Healthy Subjects.

Authors:  Patrick C Dolder; Yasmin Schmid; Andrea E Steuer; Thomas Kraemer; Katharina M Rentsch; Felix Hammann; Matthias E Liechti
Journal:  Clin Pharmacokinet       Date:  2017-10       Impact factor: 6.447
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.